Figure 1
From: Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema

Change in the mean best-corrected visual acuity. Change in the mean best-corrected visual acuity (BCVA; Early Treatment Diabetic Retinopathy Study letters) in (A) full analysis set (all participants and those with baseline BCVA of 24–73 letters) and (B) per-protocol set (all participants and those with baseline BCVA of 24–73 letters). Missing values are imputed using the “Last Observation Carried Forward” method.